Relationship between glycated hemoglobin level and duration of hypoglycemia in type 2 diabetes patients treated with sulfonylureas: A multicenter cross‐sectional study

Atsuko Matsuoka,Yushi Hirota,Akihiko Takeda,Minoru Kishi,Naoko Hashimoto,Takeshi Ohara,Satomi Higo,Hiroyuki Yamada,Tomoaki Nakamura,Tetsushi Hamaguchi,Takehito Takeuchi,Yasushi Nakagawa,Yuko Okada,Kazuhiko Sakaguchi,Wataru Ogawa

DOI: https://doi.org/10.1111/jdi.13132

2019-09-17

Journal of Diabetes Investigation

Abstract:<h3 class="article-section__sub-title section1"> Aims/ Introduction</h3><p>Sulfonylurea‐related hypoglycemia increases the risk of cardiovascular sequelae such as cardiac arrhythmia. This study aimed to clarify the relation between the level of HbA_1c and the duration of hypoglycemia in type 2 diabetes patients treated with sulfonylureas. </p><h3 class="article-section__sub-title section1"> Materials and Methods</h3><p>Glucose levels in the enrolled patients (<i>n</i> = 300) were investigated with a professional continuous glucose monitoring device in the outpatient setting at six diabetes centers in Japan. </p><h3 class="article-section__sub-title section1"> Results</h3><p>A total of 269 subjects completed the study. The duration of hypoglycemia with glucose values of &lt;54 mg/dL was significantly longer in patients with an HbA_1c level of ≤6.4% than in those with an HbA_1c level of ≥8.0%, and that of hypoglycemia with glucose values of &lt;70 mg/dL was significantly longer in patients with an HbA_1c level of ≤6.4%, 6.5–6.9%, or 7.0–7.4% than in those with an HbA_1c level of ≥8.0%. Patients with an HbA_1c level of ≤6.4% were exposed to glucose values of &lt;70 mg/dL for &gt;10% of the time in daily life (6.8 ± 5.6 min/h). The duration of hypoglycemia with glucose values of &lt;70 mg/dL was longer at night than during the daytime and the nadir of glucose values occurred between 3:00 and 5:00 a.m. irrespective of HbA_1c level. The duration of hypoglycemia was associated with the duration of diabetes and sulfonylurea dose. </p><h3 class="article-section__sub-title section1"> Conclusions</h3><p>The duration of hypoglycemia was inversely correlated with HbA_1c level and was longer during the nighttime than daytime in type 2 diabetic patients treated with sulfonylureas. </p>

endocrinology & metabolism

What problem does this paper attempt to address?

This paper aims to explore the relationship between glycated hemoglobin (HbA1c) levels and the duration of hypoglycemia in type 2 diabetic patients receiving sulfonylurea drugs. Specifically, the study focuses on how HbA1c levels affect the frequency and duration of hypoglycemic events in these patients' daily lives, especially when using a continuous glucose monitoring (CGM) system. This multicenter cross - sectional study included a total of 300 participants, and the glucose levels of the patients were monitored for 14 days in an outpatient setting through professional CGM devices.

The results of the study showed that patients with lower HbA1c levels (≤6.4%) experienced longer hypoglycemia (glucose value < 54 mg/dL or < 70 mg/dL) than those with higher HbA1c levels (≥8.0%). In addition, the duration of nocturnal hypoglycemia was longer than that during the day, and this was the case in all HbA1c groups. The study also found that the duration of hypoglycemia was related to the length of the diabetes course and the dose of sulfonylurea drugs, but not to age. Patients using dipeptidyl peptidase - 4 (DPP - 4) inhibitors or glucagon - like peptide - 1 (GLP - 1) receptor agonists had a shorter duration of hypoglycemia.

In conclusion, this study reveals an inverse correlation between HbA1c levels and the duration of hypoglycemia and emphasizes the importance of nocturnal hypoglycemia in type 2 diabetic patients treated with sulfonylurea drugs. These findings are of great significance for optimizing the treatment regimens of type 2 diabetic patients.